患者年龄与细胞浓度影响骨髓抽吸物中祖细胞的数量与浓度:436例分析
本研究对436例择期全膝或全髋关节置换术患者的髂嵴骨髓抽吸物进行分析,检测有核细胞接种后第6天的集落形成单位。结果显示年龄(p<0.05)和细胞浓度(p<0.001)显著影响结缔组织祖细胞(CTP)的患病率和浓度;年龄每增加1岁,具有至少平均CTP患病率和浓度的几率分别降低1.5%和1.6%;性别、种族、BMI和骨质疏松不影响CTP。
要点
- 年龄增长与CTP患病率和浓度降低相关,>60岁患者平均CTP浓度仅为<30岁患者的三分之一。
- 骨髓抽吸物细胞浓度与CTP患病率和浓度正相关,可在护理点测量作为质量初评。
- 性别、种族、BMI和骨质疏松不影响CTP患病率或浓度。
核心结论
- 骨髓抽吸物来源的CTP可从所有患者群体中获得,但CTP患病率和浓度随年龄增长而降低。
- 细胞浓度随年龄降低,并与总CTP患病率和浓度正相关。
研究设计与样本
- 从436例择期全膝或全髋关节置换术患者中抽取髂嵴骨髓,有核细胞以1.19×10^5 cells/cm^2密度接种,第6天进行集落形成单位分析。
主要发现
- 供者间存在 large variation。
- 年龄(p<0.05)和细胞浓度(p<0.001)显著影响CTP患病率和CTP浓度。
- 年龄每增加1岁,具有至少平均CTP患病率和浓度的几率分别降低1.5%和1.6%。
- 性别、种族、BMI和骨质疏松的存在不影响CTP患病率或CTP浓度。
关键数值与推荐
- CTP患病率定义为CTPs/百万有核细胞,CTP浓度定义为CTPs/mL。
- 年龄每增加1年,至少平均CTP患病率和浓度的几率分别降低1.5%和1.6%。
- >60岁患者平均CTP浓度是<30岁患者的三分之一。
临床怎么用
- 需要适当的BMA技术以获得高质量的细胞和CTP产量与组成。
- 可通过去除红细胞、血清和非CTP或增加抽吸量等细胞处理方法提高CTP浓度和患病率,以缓解老年人CTP降低。
- BMA中的细胞浓度可在护理点测量,作为BMA质量的适当初始评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Connective tissue progenitors (CTPs) resident in native tissues serve as biological building blocks in tissue repair and remodeling processes. Methods for analysis and reporting on CTP quantity and quality are essential for defining optimal cell sources and donor characteristics and the impact of cell processing methods for cell therapy applications. The present study examines the influence of donor characteristics and cell concentration (nucleated cells/mL) on CTP prevalence (CTPs/million nucleated cells) and CTP concentration (CTPs/mL) in bone marrow aspirates (BMAs). METHODS: Iliac crest bone marrow was aspirated from 436 patients during elective total knee or hip arthroplasty. Bone marrow-derived nucleated cells were plated at a density of 1.19 × 105 cells/cm2. Colony-forming unit analysis was performed on day 6. RESULTS: Large variation was seen between donors. Age (p < 0.05) and cell concentration (p < 0.001) significantly influenced CTP prevalence and CTP concentration. For every 1-year increase in age, the odds of having at least an average CTP prevalence and CTP concentration decreased by 1.5% and 1.6%, respectively. For every 1 million cells/mL increase in cell concentration, the odds of having at least an average CTP prevalence and CTP concentration increased by 2.2% and 7.9%, respectively. Sex, race, body mass index (BMI), and the presence of osteoporosis did not influence CTP prevalence or CTP concentration. CONCLUSIONS: BMA-derived CTPs were obtained from all patient groups. CTP prevalence and CTP concentration decreased with age. Cell concentration decreased with age and positively correlated with total CTP prevalence and CTP concentration. The mean CTP concentration in patients >60 years of age was a third of the CTP concentration in patients <30 years of age. CLINICAL RELEVANCE: Proper BMA techniques are necessary to obtain a high-quality yield and composition of cells and CTPs. The reduced CTP concentration and CTP prevalence in the elderly may be mitigated by the use of cell processing methods that increase CTP concentration and CTP prevalence (e.g., by removing red blood cells, serum, and non-CTPs or by increasing aspirate volumes). Cell concentration in the BMA can be measured at the point of care and is an appropriate initial assessment of the quality of BMA.
引用
- Mantripragada VP, Boehm C, Bova W, et al. Patient Age and Cell Concentration Influence Prevalence and Concentration of Progenitors in Bone Marrow Aspirates: An Analysis of 436 Patients. J Bone Joint Surg Am. 2021. PMID: 33844657. doi:10.2106/JBJS.20.02055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。